Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial.

Annelies Van RieElise De VosEmilyn CostaLennert VerbovenFelex NdebeleTim H HeupinkSteven Abramsnull nullBoitumelo FanampeAnneke Van der Spoel Van DykSalome CharalambousGavin ChurchyardRob Warren

Published in: Trials (2022)

ClinicalTrials.gov NCT05017324. Registered on August 23, 2021.

Keyphrases

phase iii
study protocol
phase ii
open label
double blind
clinical trial
mycobacterium tuberculosis
machine learning
case report
placebo controlled
single cell
deep learning
randomized controlled trial
hiv aids
pulmonary tuberculosis
neural network
hiv infected